Work Outsourced to Indian Biotech and Pharma Companies is Not Yet Significantly Innovative
Current Science, 102, 401-404, 2012
Posted: 1 Feb 2016 Last revised: 27 Feb 2016
Date Written: February 10, 2012
Abstract
We have examined whether – for biomedical US patents – inventors listed as based in India actually did the work in India. If so, was this work outsourced? The answer is largely 'no'. This would suggest that the skills required for drug discovery are not being honed by this route.
(Article freely downloadable from the journal website.)
Keywords: Biotech industry, pharma industry, innovation, outsourcing, patents
JEL Classification: H51, I10, L00, L33, L65, O31, O32, O33, O34, O51, O53
Suggested Citation: Suggested Citation
Soby, Sajna and Kandasamy, Muthukrishnakumar and Saberwal, Gayatri, Work Outsourced to Indian Biotech and Pharma Companies is Not Yet Significantly Innovative (February 10, 2012). Current Science, 102, 401-404, 2012, Available at SSRN: https://ssrn.com/abstract=2724520
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.